European Shortages Monitoring Platform (ESMP) training on crisis and MSSG-led preparedness reporting for marketing authorisation holders (MAHs), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 10:00 (CET) to 19 February 2025, 12:30 (CET)

Veterinary medicines European public assessment report (EPAR): Prevexxion RN, Marek's disease vaccine (live recombinant), Status: Authorised

Agenda - Management Board meeting: 13 March 2025

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID, Mycoplasma hyopneumoniae and porcine circovirus vaccine (inactivated, recombinant), Status: Authorised

Scientific advice under Article 115(5) of Regulation (EU) 2019/6 on veterinary medicinal products, regarding the list of substances essential for the treatment of equine species and for which the withdrawal period for equine species shall be six months

Veterinary medicines European public assessment report (EPAR): Porcilis PCV, adjuvanted inactivated vaccine against porcine circovirus, Status: Authorised

EMEA-002578-PIP01-19-M01

First vaccine against epizootic haemorrhagic disease recommended for approval

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025

Summary of opinion: Rheumocam, 13/03/2025 Positive